Industries > Pharma > Global Nerve Repair and Regeneration Market 2019-2029

Global Nerve Repair and Regeneration Market 2019-2029

Global Nerve Repair and Regeneration Market by Product (Nerve Monitors, Nerve Stimulation Electrodes and Probes and Accessories), Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG) and Evoked Potential (EP)) Application (Neurosurgery, Spine Surgery, ENT Surgery, Cardiovascular Applications and Other Applications), by End User (Hospitals & Surgical Centers and Ambulatory Surgical Centers), Global Opportunity Analysis and Industry Forecast

PUBLISHED: 26 March 2019
PAGES: 321
PRODUCT CODE: PHA0366
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0366 Categories: , Tag:

Market Definition:
• The nervous system is a delicate and complex structure, which constitute brain, spinal cord and peripheral nerves. There are different disorders associated with it such as Amyotrophic lateral sclerosis, Alzheimer’s disease, multiple system atrophy, Parkinson’s disease and multiple sclerosis.
• Nerve repair and regeneration generally refers to repair as well as regrowth of nervous tissues or cells. There are several mechanisms such as generation of neurons, new glia, myelin, axons, and synapses.

Market Overview and Trends
• The surgeries employed for nerve repair generally involves the exploration of the injured nerve and also the removal of injured tissue from the nerve endings. In the surgeries performed, different products related to nerve repair and regeneration are used to restore the normal functioning of nerves.
• The nerve repair and regeneration products market includes biomaterials and neuro-stimulation & neuromodulation devices. The improved efficacy of biomaterials used for treating nervous system has propelled the market growth.
• Recent advancements in nerve monitoring technology will intensify the applications and will augment business growth in foresee future.
• The growing incidence of brain disorders have further added boost to the market growth. For instance, as per CDC, in year 2017, it was reported that 5.5 million Americans had Alzheimer’s dementia and number of new cases of Alzheimer’s and other dementias is estimated to grow to its double count by 2050 annually. This is a result of the rapid rise in aging population.

Market Dynamics:

Factors Influencing the Market Growth:
• Increasing prevalence of peripheral nerve injuries and neurological diseases among geriatric population.
• Technological advancements and improving efficacy in nerve repair and regeneration products.
• Increasing healthcare expenditure and funding by government has propelled the market growth.
• Investment by key market players in R&D and further commercialization of the related products in emerging countries have fueled the market growth.

Factors Restraining the Market Growth:
• High cost of the products.
• Dearth of skilled professionals and neurologists.

Market Segmentation 2019-2029:

Product
• Neurostimulation and Neuromodulation Devices Market, 2019-2029

• Internal Neurostimulation Devices Market, 2019-2029
– Spinal Cord Stimulation
– Deep Brain Stimulation
– Vagus Nerve Stimulation
– Sacral Nerve Stimulation
– Gastric Electrical Stimulation

• External Neurostimulation Devices Market, 2019-2029
– Transcutaneous Electrical Nerve Stimulation
– Transcranial Magnetic Stimulation

• Biomaterials Market, 2019-2029
• Nerve Conduits
• Nerve Protectors
• Nerve Wraps
• Nerve Connectors

Application
• Neurostimulation and Neuromodulation Surgeries Market, 2019-2029
• Internal Neurostimulation and Neuromodulation Surgeries
• External Neurostimulation and Neuromodulation Surgeries

• Direct Nerve Repair/Neurorrhaphy Market, 2019-2029
• Epineural Repair
• Perineural Repair
• Group Fascicular Repair

• Nerve Grafting Market, 2019-2029
• Autografts
• Allografts
• Xenografts
• Stem Cell Therapy

End User
• Hospitals and Clinics Market, 2019-2029
• Ambulatory Surgical Centers Market, 2019-2029

Geographic breakdown
Focused regional forecasts and analysis explore the future opportunities:

• North America Market, 2019-2029
• U.S. Market, 2019-2029
• Canada Market, 2019-2029
• Mexico Market, 2019-2029
• Rest of North America Market, 2019-2029

• Europe Market, 2019-2029

• Germany Market, 2019-2029
• UK Market, 2019-2029
• France Market, 2019-2029
• Spain Market, 2019-2029
• Italy Market, 2019-2029
• Rest of Europe Market, 2019-2029

• Asia-Pacific Market, 2019-2029
• China Market, 2019-2029
• Japan Market, 2019-2029
• India Market, 2019-2029
• Australia Market, 2019-2029
• Malaysia Market, 2019-2029
• Rest of Asia Pacific Market, 2019-2029

• LAMEA Market, 2019-2029
• Brazil Market, 2019-2029
• Argentina Market, 2019-2029
• Turkey Market, 2019-2029
• South Africa Market, 2019-2029
• Rest of LAMEA Market, 2019-2029

Competitive Analysis:
• There are many companies operating in the market, however, number of players are entering in the market by developing more standardized and cost effective products.
• Companies are strategically expanding their global presence and offering improved products across various sectors.

Major Market Players:
• Axogen Inc., Baxter International, Inc., Boston Scientific Inc., Livanova, Integra Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Stryker Corporation, Polyganics B.V., Nuvectra, Neuropace, Orthomed and Nevro.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Nerve Repair and Regeneration Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Nerve Repair and Regeneration Market 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category